Rationale and Design of RNAFH Study: Effect of Rosuvastatin (10 mg/d) on Nonalcoholic Fatty Liver in Metabolic Syndrome Patients without Overt Diabetes Evaluated by (1)H-Magnetic Resonance Spectroscopy

Objective. The RNAFH study (effect of rosuvastatin on nonalcoholic fatty liver disease in metabolic syndrome patients without overt diabetes evaluated by (1)H-MRS) is a prospective randomized, single-center, open-label trail designed to assess the effect of rosuvastatin on the intrahepatocellular li...

Descripción completa

Detalles Bibliográficos
Autores principales: Ping, Fan, Wang, Xuan, Yang, Jing, Zhou, Mei-cen, Li, Wei, Xu, Ling-ling, Li, Yu-xiu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090105/
https://www.ncbi.nlm.nih.gov/pubmed/27872642
http://dx.doi.org/10.1155/2016/8454751

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5090105/
https://www.ncbi.nlm.nih.gov/pubmed/27872642
http://dx.doi.org/10.1155/2016/8454751

Ejemplares similares